ArticleACS medicinal chemistry letters2025

Discovery of Potent FGFR2/3 Inhibitors to Overcome Mutation Resistance and Treat Achondroplasia.

Donglin Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.